Research Project
Grant-in-Aid for Young Scientists (B)
About 30% of the 120 million people who suffer from congenital (early-onset) hearing loss are syndromic, and the remaining 70% are non-syndromic worldwide. At present, however, no effective therapies for deafness have been established except for cochlear implantation. We have recently shown that complete impairment of Y1062-phoshorylation in c-Ret causes congenital deafness in homozygous c-Ret Y1062F knock-in mice (c-Ret-KIY1062F/Y1062F-mice). On the other hand, there is no information about the relevance between c-Ret and age-related hearing loss. In this study, we used heterozygous c-Ret Y1062F knock-in mice (c-Ret-KIY1062F/+-mice) in order to analyze whether partial impairment of Y1062-phoshorylation inc-Ret causes age-related hearing loss. This study suggests that partial impairment of c-Ret causesage-related hearing loss involving neurodegeneration of spiral ganglion neurons in mice.
All 2013 2012 2011 Other
All Journal Article (19 results) (of which Peer Reviewed: 19 results) Presentation (35 results) (of which Invited: 2 results) Remarks (1 results) Patent(Industrial Property Rights) (2 results)
Environ Health Prev Med
Volume: 18 Pages: 10-15
10031143686
Dermatol. Res. Pract.
Volume: 2012 Pages: 354191-354191
J. Dermatol. Sci
Volume: 65 Pages: 207-212
Int. J. Clin. Exp. Pathol.
Volume: 5 Pages: 23-28
Neurobiol. Aging
Volume: 33
PLoS ONE.
Volume: 7
Environmental Health and Preventive Medicine
NeuroToxicology
Volume: 33 Pages: 1276-1283
PLoS ONE
J Dermatol Sci
Volume: 68 Pages: 172-178
Dermatol Res Pract
Neurobiology of Aging
Volume: 33(3)
Volume: 65(3) Pages: 207-212
Int J Clin Exp Pathol
Volume: 5(1) Pages: 23-28
Toxicol. In Vitro
Volume: 25 Pages: 623-629
J. Biol. Chem.
Volume: 286 Pages: 29621-29626
J. Skin Cancer
Volume: 2011 Pages: 730170-730170
J Biol Chem
J Skin Cancer